{"id":"https://openalex.org/W4413367166","doi":"https://doi.org/10.1093/oncolo/oyaf260","title":"Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment","display_name":"Acquired hemophilia due to immune checkpoint inhibitors: a case series introducing emicizumab treatment","publication_year":2025,"publication_date":"2025-08-19","ids":{"openalex":"https://openalex.org/W4413367166","doi":"https://doi.org/10.1093/oncolo/oyaf260","pmid":"https://pubmed.ncbi.nlm.nih.gov/40828901","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12488228"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyaf260","doi":"https://doi.org/10.1093/oncolo/oyaf260","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyaf260","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyaf260/64084966/oyaf260.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyaf260/64084966/oyaf260.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Louis Wolff","orcid":"https://orcid.org/0000-0001-9955-5433","observed_orcids":["https://orcid.org/0000-0001-9955-5433"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Louis Wolff","raw_affiliation_strings":["Belgian Multidisciplinary Immunotoxicity Board (BITOX)","Department of Internal Medicine, Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) , Brussels 1070,","Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) Department of Internal Medicine, , Brussels,"],"raw_orcid":"https://orcid.org/0000-0001-9955-5433","affiliations":[{"raw_affiliation_string":"Belgian Multidisciplinary Immunotoxicity Board (BITOX)","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) , Brussels 1070,","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]},{"raw_affiliation_string":"Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) Department of Internal Medicine, , Brussels,","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111284774","display_name":"Carolin Ertl","orcid":"https://orcid.org/0009-0000-9487-4363","observed_orcids":["https://orcid.org/0009-0000-9487-4363"]},"institutions":[{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carolin Ertl","raw_affiliation_strings":["Department of Dermatology and Allergy, LMU University Hospital, LMU Munich , Munich 80336,","Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy, LMU University Hospital, LMU Munich , Munich 80336,","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102961913","display_name":"Lucie M. Heinzerling","orcid":"https://orcid.org/0000-0001-5718-3643","observed_orcids":["https://orcid.org/0000-0001-5718-3643"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]},{"id":"https://openalex.org/I3018771216","display_name":"LMU Klinikum","ror":"https://ror.org/02jet3w32","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I4210088053","display_name":"Universit\u00e4tsklinikum Erlangen","ror":"https://ror.org/0030f2a11","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210088053"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Lucie Heinzerling","raw_affiliation_strings":["Department of Dermatology and Allergy, LMU University Hospital, LMU Munich , Munich 80336,","Department of Dermatology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Universit\u00e4tsklinikum Erlangen , Erlangen 91054,","Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany","Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Universit\u00e4tsklinikum Erlangen Department of Dermatology, , Erlangen,"],"raw_orcid":"https://orcid.org/0000-0001-5718-3643","affiliations":[{"raw_affiliation_string":"Department of Dermatology and Allergy, LMU University Hospital, LMU Munich , Munich 80336,","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Dermatology, Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Universit\u00e4tsklinikum Erlangen , Erlangen 91054,","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053"]},{"raw_affiliation_string":"Department of Dermatology and Allergy, LMU University Hospital, LMU Munich, Munich, Germany","institution_ids":["https://openalex.org/I3018771216","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (FAU), Universit\u00e4tsklinikum Erlangen Department of Dermatology, , Erlangen,","institution_ids":["https://openalex.org/I181369854","https://openalex.org/I4210088053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063737641","display_name":"Sandrine Aspeslagh","orcid":"https://orcid.org/0000-0001-6598-9161","observed_orcids":["https://orcid.org/0000-0001-6598-9161"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]},{"id":"https://openalex.org/I4210126764","display_name":"Universitair Ziekenhuis Brussel","ror":"https://ror.org/038f7y939","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210126764"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sandrine Aspeslagh","raw_affiliation_strings":["Belgian Multidisciplinary Immunotoxicity Board (BITOX)","Department of Internal Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium","Department of internal medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0001-6598-9161","affiliations":[{"raw_affiliation_string":"Belgian Multidisciplinary Immunotoxicity Board (BITOX)","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]},{"raw_affiliation_string":"Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]},{"raw_affiliation_string":"Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]},{"raw_affiliation_string":"Department of internal medicine, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033021059","display_name":"Marthe Verhaert","orcid":"https://orcid.org/0000-0002-3054-7969","observed_orcids":["https://orcid.org/0000-0002-3054-7969"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]},{"id":"https://openalex.org/I4210126764","display_name":"Universitair Ziekenhuis Brussel","ror":"https://ror.org/038f7y939","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210126764"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marthe Verhaert","raw_affiliation_strings":["Belgian Multidisciplinary Immunotoxicity Board (BITOX)","Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium"],"raw_orcid":"https://orcid.org/0000-0002-3054-7969","affiliations":[{"raw_affiliation_string":"Belgian Multidisciplinary Immunotoxicity Board (BITOX)","institution_ids":[]},{"raw_affiliation_string":"Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel) , Brussels 1090,","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]},{"raw_affiliation_string":"Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076750303","display_name":"Rapha\u00ebl Lattenist","orcid":"https://orcid.org/0000-0003-0383-9648","observed_orcids":["https://orcid.org/0000-0003-0383-9648"]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]},{"id":"https://openalex.org/I4210126764","display_name":"Universitair Ziekenhuis Brussel","ror":"https://ror.org/038f7y939","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210126764"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Raphael Lattenist","raw_affiliation_strings":["Department of Hematology, P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA , Haine Saint-Paul 7100,","Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA , Haine Saint-Paul 7100,","institution_ids":[]},{"raw_affiliation_string":"Department of Medical Oncology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090, Brussels, Belgium","institution_ids":["https://openalex.org/I13469542","https://openalex.org/I4210126764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037410632","display_name":"Caterina Confente","orcid":"https://orcid.org/0009-0000-6312-0067","observed_orcids":["https://orcid.org/0009-0000-6312-0067"]},"institutions":[{"id":"https://openalex.org/I4210107246","display_name":"H\u00f4pital de Jolimont","ror":"https://ror.org/01jn2rz36","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210107246"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Caterina Confente","raw_affiliation_strings":["Department of Medical Oncology, P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA , Haine Saint\u2011Paul 7100,","P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA Department of Hematology, , Bruxelles,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA , Haine Saint\u2011Paul 7100,","institution_ids":[]},{"raw_affiliation_string":"P\u00f4le Hospitalier Jolimont, R\u00e9seau HELORA Department of Hematology, , Bruxelles,","institution_ids":["https://openalex.org/I4210107246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051513022","display_name":"Catherine Lambert","orcid":"https://orcid.org/0000-0003-2222-0357","observed_orcids":["https://orcid.org/0000-0003-2222-0357"]},"institutions":[{"id":"https://openalex.org/I1315288073","display_name":"Cliniques Universitaires Saint-Luc","ror":"https://ror.org/03s4khd80","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I1315288073"]},{"id":"https://openalex.org/I95674353","display_name":"UCLouvain","ror":"https://ror.org/02495e989","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Catherine Lambert","raw_affiliation_strings":["Unit\u00e9 d\u2018h\u00e9mostase-thrombose, Service d\u2018h\u00e9matologie, Cliniques universitaires Saint-Luc, UCLouvain , Brussel 1200,","Cliniques universitaires Saint-Luc, UCLouvain Unit\u00e9 d\u2018h\u00e9mostase-thrombose, Service d\u2018h\u00e9matologie, , Bruxelles,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit\u00e9 d\u2018h\u00e9mostase-thrombose, Service d\u2018h\u00e9matologie, Cliniques universitaires Saint-Luc, UCLouvain , Brussel 1200,","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]},{"raw_affiliation_string":"Cliniques universitaires Saint-Luc, UCLouvain Unit\u00e9 d\u2018h\u00e9mostase-thrombose, Service d\u2018h\u00e9matologie, , Bruxelles,","institution_ids":["https://openalex.org/I1315288073","https://openalex.org/I95674353"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086203784","display_name":"Maxime Ilzkovitz","orcid":"https://orcid.org/0000-0003-2216-3495","observed_orcids":["https://orcid.org/0000-0003-2216-3495"]},"institutions":[{"id":"https://openalex.org/I132053463","display_name":"Universit\u00e9 Libre de Bruxelles","ror":"https://ror.org/01r9htc13","country_code":"BE","type":"education","lineage":["https://openalex.org/I132053463"]},{"id":"https://openalex.org/I2801838318","display_name":"Institut Jules Bordet","ror":"https://ror.org/05e8s8534","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2801838318"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Maxime Ilzkovitz","raw_affiliation_strings":["Belgian Multidisciplinary Immunotoxicity Board (BITOX)","Department of Internal Medicine, Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) , Brussels 1070,","Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) Department of Internal Medicine, , Brussels,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Belgian Multidisciplinary Immunotoxicity Board (BITOX)","institution_ids":[]},{"raw_affiliation_string":"Department of Internal Medicine, Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) , Brussels 1070,","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]},{"raw_affiliation_string":"Institut Jules Bordet, H\u00f4pital Universitaire de Bruxelles (H.U.B.), Universit\u00e9 Libre de Bruxelles (ULB) Department of Internal Medicine, , Brussels,","institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":11,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I132053463","https://openalex.org/I2801838318"],"apc_list":{"value":3852,"currency":"USD","value_usd":3852},"apc_paid":{"value":3852,"currency":"USD","value_usd":3852},"fwci":1.2455,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.7567109,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":96},"biblio":{"volume":"30","issue":"10","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acquired-hemophilia-a","display_name":"acquired hemophilia A","score":0.9269999861717224},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9909999966621399},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9129999876022339},{"id":"https://openalex.org/keywords/emicizumab","display_name":"emicizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9110000133514404},{"id":"https://openalex.org/keywords/factor-ix-inhibitors","display_name":"factor IX inhibitors","score":0.4880000054836273},{"id":"https://openalex.org/keywords/immune-thrombocytopenic-purpura","display_name":"idiopathic thrombocytopenic purpura","score":0.7390000224113464},{"id":"https://openalex.org/keywords/immunosuppressive-therapy","display_name":"immunosuppressive therapy","score":0.7929999828338623},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.7020000219345093},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8820000290870667},{"id":"https://openalex.org/keywords/autoimmune-bleeding-disorder","display_name":"autoimmune bleeding disorder","score":0.4180000126361847}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7772244215011597},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6184258460998535},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5929363965988159},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.5749092102050781},{"id":"https://openalex.org/C2993327898","wikidata":"https://www.wikidata.org/wiki/Q638729","display_name":"Immune thrombocytopenia","level":3,"score":0.5522192716598511},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4727519452571869},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3355472981929779},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32497406005859375},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3207072615623474},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3066292405128479},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006467","descriptor_name":"Hemophilia A","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1093/oncolo/oyaf260","doi":"https://doi.org/10.1093/oncolo/oyaf260","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyaf260","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyaf260/64084966/oyaf260.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:11295517","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12488228","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40828901","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40828901","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12488228","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12488228/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:262542","doi":null,"is_oa":true,"landing_page_url":"https://biblio.vub.ac.be/vubir/(d9351a38-4cb5-4c7c-a851-d2bce3c10cae).html","pdf_url":"https://biblio.vub.ac.be/vubirfiles/140349833/2025-Oncologist-SA.pdf","source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/393486","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/393486","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"The oncologist","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyaf260","doi":"https://doi.org/10.1093/oncolo/oyaf260","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyaf260","pdf_url":"https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyaf260/64084966/oyaf260.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4413367166.pdf","grobid_xml":"https://content.openalex.org/works/W4413367166.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1984592499","https://openalex.org/W2884501867","https://openalex.org/W2955241712","https://openalex.org/W3021433538","https://openalex.org/W3094562763","https://openalex.org/W4296445473","https://openalex.org/W4307263616","https://openalex.org/W4317940629","https://openalex.org/W4386271168","https://openalex.org/W4386593214","https://openalex.org/W4387666443","https://openalex.org/W4390129317","https://openalex.org/W4392844955","https://openalex.org/W4394842957","https://openalex.org/W4404424536"],"related_works":["https://openalex.org/W4394842957","https://openalex.org/W4297255276","https://openalex.org/W4412973857","https://openalex.org/W4307263616","https://openalex.org/W4403092238","https://openalex.org/W3211794003","https://openalex.org/W4280596715","https://openalex.org/W7133721145","https://openalex.org/W4379508822","https://openalex.org/W2914044482"],"abstract_inverted_index":{"BACKGROUND:":[0],"Acquired":[1],"hemophilia":[2],"A":[3,71,82],"(AHA)":[4],"is":[5,213],"a":[6,57,90,141,162,199],"rare":[7],"but":[8],"potentially":[9,163],"life-threatening":[10],"autoimmune":[11],"bleeding":[12],"disorder":[13],"and":[14,36,66,150,198,220],"immune-related":[15],"adverse":[16],"event":[17],"(irAE)":[18],"associated":[19],"with":[20,89,105,139,178],"immune":[21],"checkpoint":[22],"inhibitors":[23],"(ICI).":[24],"This":[25],"study":[26],"discusses":[27],"3":[28],"new":[29],"cases":[30],"of":[31,48,84,93,123,127,175,196],"ICI-induced":[32,159],"AHA":[33,124,160,172],"from":[34],"Belgium":[35],"the":[37,46,114,131,218],"SERIO-Side":[38],"Effect":[39],"Registry":[40],"Immuno-Oncology":[41],"(www.serio-registry.org),":[42],"placing":[43],"them":[44],"in":[45,61,125,202,208],"context":[47],"existing":[49],"literature.":[50],"METHODS:":[51],"One":[52],"case":[53],"was":[54,64,136],"encountered":[55],"at":[56],"tertiary":[58],"care":[59],"center":[60],"Belgium.":[62],"SERIO":[63],"queried":[65],"yielded":[67],"another":[68],"2":[69],"cases.":[70,80],"comprehensive":[72],"literature":[73],"review":[74],"using":[75],"PubMed":[76],"identified":[77],"8":[78],"additional":[79],"RESULTS:":[81],"total":[83],"11":[85,128],"patients":[86],"were":[87,99,103],"analyzed,":[88],"median":[91],"age":[92],"68":[94],"years":[95],"(range:":[96],"56-71),":[97],"10":[98],"male.":[100],"Most":[101],"(9/11)":[102],"treated":[104,138],"anti-PD-1":[106],"monotherapy.":[107],"In":[108],"5":[109],"cases,":[110],"toxicity":[111],"appeared":[112],"before":[113],"fourth":[115],"cycle.":[116],"Immunosuppressive":[117],"therapy":[118],"successfully":[119,137],"achieved":[120],"complete":[121],"resolution":[122],"9":[126],"patients.":[129,210],"For":[130],"first":[132],"time,":[133],"one":[134],"patient":[135],"emicizumab,":[140],"monoclonal":[142],"bispecific":[143],"antibody,":[144],"which":[145],"bridges":[146],"activated":[147],"factor":[148,151],"IX":[149],"X.":[152],"CONCLUSIONS:":[153],"Clinicians":[154],"should":[155,184],"be":[156,185],"vigilant":[157],"about":[158],"as":[161],"severe":[164],"irAE.":[165],"Prolonged":[166],"aPTT":[167],"requires":[168],"thorough":[169],"evaluation.":[170],"Upon":[171],"confirmation,":[173],"eradication":[174],"anti-FVIII":[176],"antibodies":[177],"corticosteroids,":[179],"rituximab,":[180],"or":[181],"other":[182],"immunosuppressant":[183],"attempted.":[186],"Emicizumab":[187],"offers":[188],"advantages":[189],"over":[190],"traditional":[191],"replacement":[192],"therapy,":[193],"including":[194],"ease":[195],"use":[197],"potential":[200],"reduction":[201],"immunosuppressive":[203],"drug":[204],"requirements-an":[205],"important":[206],"consideration":[207],"ICI-treated":[209],"Further":[211],"research":[212],"needed":[214],"to":[215],"fully":[216],"understand":[217],"pathophysiology":[219],"optimize":[221],"treatment":[222],"strategy":[223],"for":[224],"AHA.":[225]},"counts_by_year":[{"year":2026,"cited_by_count":2}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2025-10-10T00:00:00"}